254 related articles for article (PubMed ID: 1740516)
1. Plasma viscosity in inflammatory bowel disease.
Lobo AJ; Jones SC; Juby LD; Axon AT
J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
Niederau C; Backmerhoff F; Schumacher B; Niederau C
Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
[TBL] [Abstract][Full Text] [Related]
3. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Tarui S; Okamoto M
Gut; 1992 Jul; 33(7):914-21. PubMed ID: 1644331
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.
Fagan EA; Dyck RF; Maton PN; Hodgson HJ; Chadwick VS; Petrie A; Pepys MB
Eur J Clin Invest; 1982 Aug; 12(4):351-9. PubMed ID: 6814926
[TBL] [Abstract][Full Text] [Related]
6. Serum nitrate levels in ulcerative colitis and Crohn's disease.
Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
[TBL] [Abstract][Full Text] [Related]
7. Differing acute phase responses in Crohn's disease and ulcerative colitis.
Saverymuttu SH; Hodgson HJ; Chadwick VS; Pepys MB
Gut; 1986 Jul; 27(7):809-13. PubMed ID: 3732890
[TBL] [Abstract][Full Text] [Related]
8. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
[TBL] [Abstract][Full Text] [Related]
10. Laboratory markers of colonoscopic activity in ulcerative colitis and Crohn's colitis.
Moran A; Jones A; Asquith P
Scand J Gastroenterol; 1995 Apr; 30(4):356-60. PubMed ID: 7610352
[TBL] [Abstract][Full Text] [Related]
11. Serum immunoglobulin G subclasses in patients with ulcerative colitis and Crohn's disease of different disease activities.
Philipsen EK; Bondesen S; Andersen J; Larsen S
Scand J Gastroenterol; 1995 Jan; 30(1):50-3. PubMed ID: 7701250
[TBL] [Abstract][Full Text] [Related]
12. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
Folwaczny C; Wiebecke B; Loeschke K
Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
[TBL] [Abstract][Full Text] [Related]
13. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
14. Poor diagnostic value of colonic CD44v6 expression and serum concentrations of its soluble form in the differentiation of ulcerative colitis from Crohn's disease.
Reinisch W; Heider KH; Oberhuber G; Dejaco C; Müllner M; Adolf GR; Gasché C
Gut; 1998 Sep; 43(3):375-82. PubMed ID: 9863483
[TBL] [Abstract][Full Text] [Related]
15. Zinc status in inflammatory bowel disease.
Ainley CC; Cason J; Carlsson LK; Slavin BM; Thompson RP
Clin Sci (Lond); 1988 Sep; 75(3):277-83. PubMed ID: 3416562
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
17. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
[TBL] [Abstract][Full Text] [Related]
18. Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.
Macfarlane PI; Miller V; Wells F; Richards B
J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):93-6. PubMed ID: 3944748
[TBL] [Abstract][Full Text] [Related]
19. [Value of C-reactive protein in the evaluation of activity in ulcerative colitis and Crohn's disease].
Vucelić B; Krznarić Z; Sentić M; Milicić D; Korać B; Cvorisćec D; Stavljenić A
Lijec Vjesn; 1990; 112(9-10):281-4. PubMed ID: 2093781
[TBL] [Abstract][Full Text] [Related]
20. Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
Miranda-García P; Chaparro M; Gisbert JP
Gastroenterol Hepatol; 2016 Oct; 39(8):508-15. PubMed ID: 27020243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
